Science and Technology Select Committee
EU Membership and UK Science

2nd Report of Session 2015-16 - published 20 April 2016 - HL Paper 127

Contents

Summary of Conclusions and recommendations

Chapter 1: Introduction

The context for our inquiry

The goals of our inquiry

The UK science community and EU membership

Identifying witnesses and evidence

Chapter 2: Regulatory framework

The EU regulatory environment

Chapter 3: Scientific advice and influence

Scientific advice for EU policy-making

Figure 1: Operation of the Scientific Advice Mechanism

UK influence on EU policy for science

EU influence on UK international scientific relations

Chapter 4: Funding

The EU funding system supporting science and research

Figure 2: An attempt to capture the principal mechanisms established by the EU to support science and research

Figure 3: EU estimated expenditure on research, development
and innovation 2014–20 including a breakdown of expenditure
within Horizon 2020 and a breakdown of the Excellent Science
pillar of Horizon 2020

Structural and Investment Funds

Sectoral research and development programmes and other connected programmes

UK funding for science and research in the EU

Figure 4: Flow of funds between the UK and the EU (2007–13)

EU funding for science and research in the UK

Figure 5: Total FP7 funds awarded against member states

Figure 6: Total FP7 funds awarded against member states per
unit GDP

Figure 7: Total FP7 funds awarded against member states per
capita

Figure 8: Total FP7 funds awarded against member states per national Field Weighted Citation Impact

Figure 9: Total structural funds allocated for research and innovation against member states

Figure 10: Sum of total FP7 funds awarded and total structural funds allocated for research and innovation against member
states

Figure 11: Sum of total FP7 funds awarded and structural funds allocated for research and innovation against member states per unit GDP

Figure 12: FP7 funding awarded to UK by sector (2007–13)

Figure 13: UK expenditure on R&D by source of funding
(2007–13)

Business and innovation

Figure 14: Percentage of FP7 funding awarded to businesses in
the UK and key competitor nations (2007–13)

Chapter 5: Collaboration

Researcher mobility

Shared research infrastructures

European Molecular Biology Laboratory European
Bioinformatics Institute (EMBL-EBI) and ELIXIR

European Social Survey (ESS)

European Organisation of Nuclear Research (CERN)

The ITER nuclear fusion experiment

Chapter 6: Scenarios

Repatriation of EU funds

Contingency planning in the event of Brexit

A new regulatory framework for the UK

Associated Country Status

The UK remains in the EU

Appendix 1: List of Members and declaration of interest

Appendix 2: List of witnesses

Appendix 3: Call for evidence

Appendix 4: Seminar held at the House of Lords on 1 December
2015

Appendix 5: Abbreviations, acronyms and technical terms

Appendix 6: Member Countries of the EU and Associated
Countries

Appendix 7: Additional presentation of data on FP7 and structural
funding for research and innovation as presented by the Royal
Society

Evidence is published online at www.parliament.uk/hlscience and available for inspection at the Parliamentary Archives (020 7129 3074).

Q in footnotes refers to a question in oral evidence.

© Parliamentary copyright 2016